In ELS models, long-term glial activation has been related to behavioral impairments and epileptogenesis (de Oliveira et al., 2008), while treatment with inflammatory inhibitors resulted in reductions of GFAP and cognitive impairments (Abraham et al., 2012; Somera-Molina et al., 2007). Here, GFAP is linked to Cognitive impairment.